CHOPIN Study
Evaluation of the therapeutic effect of lanadelumab used in Polish patients with hereditary angioedema as part of the Drug Program.
NON-INTERVENTIONAL STUDY
To start entering registration data, please enter the access code and then click the "Register" button.
Access key
BioStat® is responsible for the smooth conduct of the study and data analysis.
For any inquiries, please contact the organizer's office at the following address:
BioStat Sp. z o.o.
ul. Kowalczyka 17, 44-206 Rybnik
tel: 666 069 814
email:
[email protected]
The study is sponsored by Takeda Pharma sp. z o.o.
Takeda Pharma sp. z o.o.
ul. Prosta 68, 00-838 Warsaw
tel: +48 22 608 13 00/01
fax: +48 22 608 13 03
VV-MEDMAT-27074
FAQ / Privacy Policy / Cookies